HIV-1 diversity and drug resistance mutations among people seeking HIV diagnosis in voluntary counseling and testing sites in Rio de Janeiro, Brazil

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Velasco de Castro, Carlos A ^a,b   Grinsztejn, Beatriz ^b   Veloso, Valdiléa G ^b   Bastos, Francisco I ^a,c,d   Pilotto, José H ^a,e   Fernandes, Nilo ^b   Morgado, Mariza G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c Oswaldo Cruz Foundation   (Brazil)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Hospital Geral de Nova Iguacu   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BRAZIL; FEMALE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE F; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEROCONVERSION; STRUCTURAL GENE; VIRUS GENOME; VIRUS MUTATION; VIRUS RECOMBINANT;

ADOLESCENT; ADULT; BRAZIL; COUNSELING; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; PREVALENCE; YOUNG ADULT;

EID: 84900394004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087622     Document Type: Article

References (43)

1. UNAIDS (2012) Global report: UNAIDS report on the global AIDS epidemic 2012.
2. UNAIDS (2010) Global report: UNAIDS report on the global AIDS epidemic 2010.
3. Szwarcwald CL, Barbosa Junior A, Souza-Junior PR, Lemos KR, Frias PG, et al. (2008) HIV testing during pregnancy: use of secondary data to estimate 2006 test coverage and prevalence in Brazil. Braz J Infect Dis 12: 167-172.
4. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, et al. (2008) Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455: 661-664.
5. Hemelaar J, Gouws E, Ghys PD, Osmanov S (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. Aids 25: 679-689.
6. Almeida SE, de Medeiros RM, Junqueira DM, Graf T, Passaes CP, et al. (2012) Temporal dynamics of HIV-1 circulating subtypes in distinct exposure categories in southern brazil. Virol J 9: 306.
7. Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860. (Pubitemid 28135961)
8. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532-539.
9. Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, et al. (2010) Expanding access to HAART: a cost-effective approach for treating and preventing HIV. Aids 24: 1929-1935.
10. Tamalet C, Fantini J, Tourres C, Yahi N (2003) Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes. Aids 17: 2383-2388. (Pubitemid 38147025)
11. Scott P, Arnold E, Evans B, Pozniak A, Moyle G, et al. (2004) Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. J Antimicrob Chemother 53: 469-473. (Pubitemid 38380245)
12. Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, et al. (2004) The prevalence of antiretroviral drug resistance in the United States. Aids 18: 1393-1401. (Pubitemid 38925131)
13. Taniguchi T, Nurutdinova D, Grubb JR, Önen NF, Shacham E, et al. (2012). Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy. AIDS Res Hum Retroviruses 28:259-64.
14. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, et al. (2003) Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. Aids 17: 1063-1069. (Pubitemid 36549719)
15. Inocencio LA, Pereira AA, Sucupira MC, Fernandez JC, Jorge CP, et al. (2009) Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc 12: 20.
16. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS (2004) Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 42: 2623-2628. (Pubitemid 38747513)
17. de Castro CA, Grinsztejn B, Veloso VG, Bastos FI, Pilotto JH, et al. (2010) Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil. BMC Infect Dis 10: 224.
18. Eyer-Silva WA, Morgado MG (2006) Molecular epidemiology of HIV-1 infection in a small Brazilian county: usefulness of envelope and polymerase sequences to epidemiologic studies. J Acquir Immune Defic Syndr 41: 664-670.
19. Burland TG (2000) DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 132: 71-91.
20. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
21. Kumar S, Tamura K, Nei M (2004) MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5: 150-163.
22. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, et al. (2005) An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21: 3797-3800. (Pubitemid 41535530)
23. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkari D, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73(1): 152-160. (Pubitemid 28565356)
24. Gifford RJ, Liu TF, Rhee SY, Kiuchi M, Hue S, et al. (2009) The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance. Bioinformatics 25: 1197-1198.
25. Shafer RW, Rhee SY, Bennett DE (2008) Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir Ther 13 Suppl 2: 59-68. (Pubitemid 352019090)
26. Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF (2008) Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 13 Suppl 2: 25-36. (Pubitemid 352019087)
27. Pires IL, Soares MA, Speranza FA, Ishii SK, Vieira MC, et al. (2004) Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. J Clin Microbiol 42: 426-430.26
28. Barreto CC, Nishyia A, Araujo LV, Ferreira JE, Busch MP, et al. (2006) Trends in antiretroviral drug resistance and clade distributions among HIV-1-infected blood donors in Sao Paulo, Brazil. J Acquir Immune Defic Syndr 41: 338-341.
29. Delatorre EO, Bello G, Eyer-Silva WA, Chequer-Fernandez SL, Morgado MG, et al. (2012) Evidence of multiple introductions and autochthonous transmission of the HIV type 1 CRF02-AG clade in Brazil. AIDS Res Hum Retroviruses 28: 1369-1372.
30. Machado LF, Ishak MO, Vallinoto AC, Lemos JA, Azevedo VN, et al. (2009) Molecular epidemiology of HIV type 1 in northern Brazil: identification of subtypes C and D and the introduction of CRF02-AG in the Amazon region of Brazil. AIDS Res Hum Retroviruses 25: 961-966.
31. Pilotto JH, Grinsztejn B, Veloso VG, Velasque LS, Friedman RK, et al. (2013) Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 29(4): 681-6.
32. Ferreira FG, Pinto JA, Kakehasi FM, Cleto S, Tupinambás U, et al. (2010) Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil. AIDS Res Hum Retroviruses. 26(2): 229-32.
33. Triques K, Bourgeois A, Vidal N, Mpoudi-Ngole E, Mulanga-Kabeya C, et al. (2000) Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses. 16(2): 139-51. (Pubitemid 30060984)
34. Brindeiro R, Vanderborght B, Caride E, Correa L, Oravec RM, et al. (1999) Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. Antimicrob Agents Chemother 43: 1674-1680. (Pubitemid 29331246)
35. Dumans AT, Soares MA, Pieniazek D, Kalish ML, De Vroey V, et al. (2002) Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. Antimicrob Agents Chemother 46: 3075-3079.
36. Sprinz E, Netto EM, Patelli M, Lima JS, Furtado JJ, et al. (2009) Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses 25: 861-867.
37. Arruda E, Simoes L, Sucupira C, Medeiros M, Arruda E, et al. (2011) Short communication: intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil. AIDS Res Hum Retroviruses 27: 153-156.
38. Bermudez-Aza EH, Kerr LR, Kendall C, Pinho AA, de Mello MB, et al. (2011) Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil. J Acquir Immune Defic Syndr 57 Suppl 3: S186-192.
39. Vicente AC, Otsuki K, Silva NB, Castilho MC, Barros FS, et al. (2000) The HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F. J Acquir Immune Defic Syndr 23: 327-331. (Pubitemid 30327035)
40. Guimarães ML, Couto-Fernandez JC, Eyer-Silva WA, Teixeira SL, Chequer-Fernandez SL, et al. (2010) Analysis of HIV-1 BF pr/rt recombinant strains from Rio de Janeiro/Brazil reveals multiple unrelated mosaic structures. Infect Genet Evol. 10(7): 1094-100.
41. Gräf T, Passaes CP, Ferreira LG, Grisard EC, Morgado MG, et al. (2011) HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories. J Clin Virol. 51(3):186-91.
42. Ferreira AS, Cardoso LP, Stefani MM (2011) Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. J Med Virol. 83(8):1301-7.
43. Dobbs T, Parekh BS (2003) Detecting recent human immunodeficiency virus type 1 infection: why and how? MLO Med Lab Obs 35: 12-14, 16, 19-20 passim; quiz 24-15.